tiprankstipranks
Trending News
More News >
Easton Pharmaceuticals Inc (EAPH)
OTHER OTC:EAPH
US Market

Easton Pharmaceuticals (EAPH) Income Statement

Compare
90 Followers

Easton Pharmaceuticals Income Statement

Last quarter (Q3 2021), Easton Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Easton Pharmaceuticals's net income was $-84.35K. See Easton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 1.56M$ 378.59K
Gross Profit
$ 0.00$ 201.40K$ 106.91K
Operating Expenses
$ 188.54K$ 523.57K$ 231.13K
Depreciation and Amortization
$ 180.67K$ 316.41K$ 119.06K
EBITDA
$ -8.33K$ -6.59K$ -124.00K
Operating Income
$ -189.00K$ -322.00K$ -124.00K
Other Income/Expenses
$ 0.00$ -1.00K$ -45.00K
Pretax Income
$ -189.00K$ -323.00K$ -169.00K
Net Income
$ -189.00K$ -323.00K$ -169.00K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ >-0.01
Diluted EPS
$ 0.00$ 0.00$ >-0.01
Weighted Average Shares Outstanding
1.34B 1.34B 1.21B
Weighted Average Shares Outstanding (Diluted)
1.34B 1.34B 1.21B
Currency in USD

Easton Pharmaceuticals Earnings and Revenue History